MDT

96.53

+0.95%↑

VEEV

287.9

+0.6%↑

A

138.07

-0.18%↓

HQY

93.65

+0.53%↑

PHR.US

22.97

+3.56%↑

MDT

96.53

+0.95%↑

VEEV

287.9

+0.6%↑

A

138.07

-0.18%↓

HQY

93.65

+0.53%↑

PHR.US

22.97

+3.56%↑

MDT

96.53

+0.95%↑

VEEV

287.9

+0.6%↑

A

138.07

-0.18%↓

HQY

93.65

+0.53%↑

PHR.US

22.97

+3.56%↑

MDT

96.53

+0.95%↑

VEEV

287.9

+0.6%↑

A

138.07

-0.18%↓

HQY

93.65

+0.53%↑

PHR.US

22.97

+3.56%↑

MDT

96.53

+0.95%↑

VEEV

287.9

+0.6%↑

A

138.07

-0.18%↓

HQY

93.65

+0.53%↑

PHR.US

22.97

+3.56%↑

Search

Odonate Therapeutics Inc

Closed

0

Overview

Share price change

24h

Current

Min

Max

Key metrics

By Trading Economics

Odonate Therapeutics Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

14 paź 2025, 22:33 UTC

Earnings

America Movil 3Q Profit Jumps on Higher Revenue, Lower Financial Costs

14 paź 2025, 22:21 UTC

Major Market Movers

Dentsply Sirona Shares Rise After SEC Probe Ends

14 paź 2025, 19:27 UTC

Acquisitions, Mergers, Takeovers

Bouygues Telecom, Free-iliad, Orange Offer to Buy Most Altice French Assets for About $20 Billion

14 paź 2025, 17:56 UTC

Major Market Movers

Nova Minerals Surges; Will Provide Minerals Briefing to Australian Government Ahead of Trump Meeting

14 paź 2025, 23:38 UTC

Market Talk

Nikkei May Rise Amid Possible Bargain-Hunting -- Market Talk

14 paź 2025, 22:12 UTC

Market Talk
Earnings

Fletcher Building's 1H Earnings Likely Down 16% -- Market Talk

14 paź 2025, 21:40 UTC

Earnings

America Movil 3Q EBITDA MXN93.82B, Up 4.9% on Year >AMX.MX

14 paź 2025, 21:39 UTC

Earnings

America Movil 3Q Rev MXN232.92B, Up 4.2% on Year >AMX.MX

14 paź 2025, 21:38 UTC

Earnings

America Movil 3Q Net MXN22.7B Vs. Net MXN6.43B Year Ago >AMX.MX

14 paź 2025, 21:06 UTC

Earnings

These Stocks Moved the Most Today: JPMorgan, Wells Fargo, Goldman, AMD, Walmart, J&J, Navitas, Polaris, and More -- Barrons.com

14 paź 2025, 20:50 UTC

Market Talk
Earnings

Financial Services Roundup: Market Talk

14 paź 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

14 paź 2025, 20:50 UTC

Market Talk

Auto & Transport Roundup: Market Talk

14 paź 2025, 20:50 UTC

Market Talk
Earnings

Health Care Roundup: Market Talk

14 paź 2025, 20:13 UTC

Earnings

BlackRock's Assets Hit Record $13.5 Trillion After Market Rally, Dealmaking Spree -- 2nd Update

14 paź 2025, 20:01 UTC

Earnings

Goldman Sachs Profit Surges, Fueled by Dealmaking Boom -- 5th Update

14 paź 2025, 19:21 UTC

Market Talk
Earnings

Citigroup's Higher Outlook Leaves Questions -- Market Talk

14 paź 2025, 19:12 UTC

Acquisitions, Mergers, Takeovers

Bouygues Telecom, Free-iliad, Orange Offer to Buy Most Altice French Assets for About $20B

14 paź 2025, 19:08 UTC

Market Talk

Oil Futures Settle Lower on Trade, Oversupply Concerns -- Market Talk

14 paź 2025, 19:02 UTC

Market Talk

U.S. Natural Gas Falls as Weather Outlook Stays Mild -- Market Talk

14 paź 2025, 18:59 UTC

Acquisitions, Mergers, Takeovers

Bouygues Telecom, Free-iliad Group, Orange Bid for Corresponds to Total Enterprise Value of EUR17B for Altice France Assets

14 paź 2025, 18:58 UTC

Acquisitions, Mergers, Takeovers

Bouygues Telecom, Free-iliad Group, Orange Bid Excludes Stakes in Intelcia, UltraEdge, XP Fibre, Altice Technical Services

14 paź 2025, 18:58 UTC

Acquisitions, Mergers, Takeovers

Bouygues Telecom, Free-iliad Group, Orange Bid Covers Most SFR Assets

14 paź 2025, 18:56 UTC

Acquisitions, Mergers, Takeovers

Bouygues Telecom, Free-iliad Group, Orange Submit Joint Non-Binding Offer to Buy Large Part of Altice's Activities in France

14 paź 2025, 18:46 UTC

Earnings

These Stocks Are Moving the Most Today: JPMorgan, Wells Fargo, Goldman, AMD, Walmart, J&J, Navitas, Polaris, and More -- Barrons.com

14 paź 2025, 18:04 UTC

Earnings

Goldman Sachs Profit Surges, Fueled by Dealmaking Boom -- 4th Update

14 paź 2025, 18:01 UTC

Market Talk

Gold Finds Another Record as Traders Eye Further Upside -- Market Talk

14 paź 2025, 17:54 UTC

Earnings

Salesforce's Dreamforce Conference Kicks Off. CEO Benioff Touts AI Tool Agentforce. -- Barrons.com

14 paź 2025, 17:50 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

14 paź 2025, 17:50 UTC

Market Talk

Lower Dollar Provides Some Strength in Grains -- Market Talk

Peer Comparison

Price change

Odonate Therapeutics Inc Forecast

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

EBITDA

Operating profit

$

About Odonate Therapeutics Inc

Odonate, Inc., a pharmaceutical company, develops therapeutics for the treatment of cancer. It is developing tesetaxel, an orally administered chemotherapy agent, which is in Phase III clinical study for patients with metastatic breast cancer. The company was formerly known as Odonate Therapeutics, Inc. and changed its name to Odonate, Inc. in March 2023. The company was founded in 2013 and is based in New York, New York.
help-icon Live chat